已收盤 10-24 16:00:00 美东时间
+0.310
+1.21%
Kestra Medical Technologies, Ltd. announced the appointment of Timothy Moran as Chief Business Officer, effective November 3. With over 25 years of experience in medtech, Moran will oversee business strategy, payor engagement, and revenue management. Previously, he led the launch of an implantable cardiac device at Avertix Medical and served as CEO of Motus GI Holdings. Kestra's President Brian Webster expressed confidence in Moran's ability to a...
10-07 12:00
Kestra Medical Technologies debuts at the 2025 HFSA Annual Scientific Meeting in Minneapolis, showcasing its Cardiac Recovery System (CRS) platform, which combines protection against sudden cardiac death with actionable insights for heart failure recovery. The platform features the ASSURE Wearable Cardioverter Defibrillator and offers immersive demonstrations highlights its ability to empower clinicians and support vulnerable patients. Kestra CEO...
09-25 12:00
Kestra Medical Technologies, Ltd. has appointed Elizabeth Kwo, M.D., as an independent director, recognizing her extensive experience in digital health and patient care innovation. Dr. Kwo, currently Chief Commercial Officer at Everly Health, brings expertise in scaling health platforms and advancing data-driven care models. Her加入将助力Kestra加速其心脏恢复系统的采用,推动公司使命,惠及患者和医疗提供者。
09-17 12:00
Black Rock Coffee Bar, Inc.涨37.6%;IBEX Holdings涨36.5%;Wolfspeed涨23.9%
09-13 11:18
Kestra Medical Technologies shares are trading higher after the company reporte...
09-13 00:58
Kestra Medical Technologies Ltd. ( ($KMTS) ) has released its Q1 earnings. Here...
09-12 11:58
Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.85) by 41.38 percent. This is a 55.36 percent increase over losses of $(1.12) per share
09-12 04:03
Companies Reporting Before The Bell • Kroger (NYSE:KR) is expected to report qu...
09-11 16:32
Kestra Medical Technologies Ltd. ( ($KMTS) ) has shared an update. Kestra Medic...
09-05 05:19
InspireMD聘请Raymond W. Cohen为董事会成员,其拥有40年以上医疗科技领导经验,曾成功推动Axonics以37亿美元被Boston Scientific收购。InspireMD近期获FDA批准,即将推出CGuard Prime钴基颈动脉支架系统,Cohen的加入将助力公司加速商业化进程并提升长期价值。
07-31 12:31